QL Biotech's Mycoplasma IgM Test – Revolutionary CK-MB Rapid Test Device

Short Description:

The CK‐MB Rapid Test Device (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of human CK‐MB in whole blood, serum or plasma as an aid in the diagnosis of myocardial infarction (MI).


Product Detail

Product Tags

Dive into the new era of CK-MB testing with QL Biotech’s advanced product, the Mycoplasma IgM Test. This Rapid Test Device has been specially designed to provide you with the utmost accuracy in a significantly shorter time. QL Biotech’s Mycoplasma IgM Test kit is an all-inclusive package. Each kit comes with individually packed test devices that are user-friendly and convenient to handle. We provide you with disposable pipettes that enhance the precision and consistency of your results. They are excellent for transporting a measured volume of liquid, eliminating wastage, and ensuring tidiness during the process. One of the highlights of our testing kit is the Buffer solution. It helps increase the stability and sustainability of biological samples and contributes to the reliability of the test results. Furthermore, the package insert comprising detailed instructions about the usage of a Mycoplasma IgM Test is also included. This guide is perfect for first-time users and serves as a handy manual for professionals too.

KIT COMPONENTS

● Individually packed test devices
● Disposable pipettes
● Buffer
● Package insert
●Each device contains a strip with colored conjugates ,and reactive reagents pre‐spreaded at the , corresponding regions , For adding specimens use,Phosphate buffered saline and preservative,For operation instruction.

PRECAUTIONS

  • ● For professional in vitro diagnostic use only. Do not use after expiration date.
  • ● The test must remain in the sealed pouch until use.
  • ● Do not eat, drink or smoke in the area where the specimens or kits are handled.
  • ● Do not use if pouch is damaged.
  • ● Handle all specimens as if they contain infectious agents. Observe established precautions against microbiological hazards throughout the procedure and follow the standard procedures for proper disposal of specimens.
  • ● Wear protective clothing such as laboratory coats, disposable gloves or eye protection when specimens are being tested.
  • ● Humidity and temperature can adversely affect results.

EXPECTED VALIES

The CK‐MB Rapid Test Device (Whole Blood/Serum/Plasma) has been compared with a leading commercial CK‐MB EIA test, demonstrating an overall accuracy of 99.8%.

PERFORMANCE CHARACTERISTICS

Sensitivity and Specificity
The CK‐MB Rapid Test Device (Whole Blood/Serum/Plasma) has been evaluated with a leading commercial CK‐ MB EIA test using clinical specimens. The results show that the sensitivity of the CK‐MB Rapid Test Device (Whole Blood/Serum/Plasma) is 100% and the specificity is 99.8% relative to the leading EIA test.

CK‐MB Rapid Test vs. EIA

Method

EIA

Total Results

CK‐MB Rapid Test

 Results

Positive

Negative

 

 Positive

55

1

56

 Negative

 0

 425

 425

Total Results

 54

 426

 481


Relative  Sensitivity:  100% (99.7%‐100.0%) *     
Relative  Specificity:  99.8% (99.3%‐100%)*
Accuracy: 99.8%(99.4%-100%)* 95% Confidence Interval
 


Perhaps the most impressive aspect of our CK-MB Rapid Test Device is the specially crafted strip it contains. This strip is imbibed with colored conjugates and reactive reagents carefully spread at precise locations. When used in conjunction with our superior quality phosphate-buffered saline and preservative, this strip guarantees highly precise results. The Mycoplasma IgM Test is a breakthrough in the field of medical testing. It is designed keeping in mind the ease of operation and the need for accurate results. We at QL Biotech are committed to enhancing your testing experience with this comprehensive kit. This Rapid Test Device is a true testimony to our dedication to delivering top-notch quality products. Explore the realm of rapid testing with QL Biotech’s Mycoplasma IgM Test.

  • Previous:
  • Next: